These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4735311)

  • 1. James L. Goddard, M.D., Former FDA commissioner, statement to Senate Subcommittee on Health.
    Goddard JL
    J Tenn Med Assoc; 1973 Apr; 66(4):382-3. PubMed ID: 4735311
    [No Abstract]   [Full Text] [Related]  

  • 2. An interview with Dr. James L. Goddard.
    Callahan B
    Hosp Prog; 1967 Sep; 48(9):62-6. PubMed ID: 6073602
    [No Abstract]   [Full Text] [Related]  

  • 3. An interview with FDA commissioner Hayes.
    Small WE
    Am Pharm; 1981 Oct; NS21(10):27-36. PubMed ID: 6803557
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA commissioner discusses issues of concern to hospital pharmacists. Interview by William A. Zellmer.
    Goyan JE
    Am J Hosp Pharm; 1980 May; 37(5):738-40 contd. PubMed ID: 7386484
    [No Abstract]   [Full Text] [Related]  

  • 5. ASHP statement on the use of medications for unlabeled uses.
    Am J Hosp Pharm; 1992 Aug; 49(8):2006-8. PubMed ID: 1442846
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA extra-label restriction on drugs.
    Varney JE
    J Am Vet Med Assoc; 1983 Dec; 183(12):1372, 1374-5. PubMed ID: 6654717
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA crackdown on illegal products.
    FDA Consum; 2004; 38(2):36-7. PubMed ID: 15101364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of human-label drugs in veterinary medicine.
    Reid JS
    J Am Vet Med Assoc; 1988 Jan; 192(2):247-9. PubMed ID: 3350756
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA reform in Congress: FDA's concerns. Food and Drug Administration.
    James JS
    AIDS Treat News; 1996 Apr; (no 245):5-7. PubMed ID: 11363624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current FDA policy on use of human-labeled drugs in animals.
    Teske RH
    J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
    [No Abstract]   [Full Text] [Related]  

  • 11. Delegations of authority and organization; issuance of written notices--FDA. Final rule.
    Fed Regist; 1992 May; 57(85):18823-4. PubMed ID: 10118461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food labeling: health claims; garlic, reduction of serum cholesterol, and the risk of cardiovascular disease in adults--FDA. Interim final rule.
    Fed Regist; 1998 Jun; 63(119):34110-2. PubMed ID: 10180290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point of law: what are the legal implications of prescribing and administering FDA-approved drugs in nonapproved ways?
    Kaunitz AM
    Hosp Med Staff; 1982 Feb; 11(2):15-8. PubMed ID: 10254209
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on the AVMA drug Availability Committee Statement to FDA Commissioner Kennedy.
    Crawford LM
    J Am Vet Med Assoc; 1979 Apr; 174(8):854-6. PubMed ID: 500428
    [No Abstract]   [Full Text] [Related]  

  • 16. Are "off-labels" legal?
    Price EC
    Mich Health Hosp; 1998; 34(6):20-1. PubMed ID: 10187136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug problems in the WHO].
    Lindgren SA
    Lakartidningen; 1966 Jul; 63(28):2641-4. PubMed ID: 5953348
    [No Abstract]   [Full Text] [Related]  

  • 18. Statement before the subcommittee on (the) Consumer Committee on Commerce, U.S. Senate October 1, 1969.
    Wegner G
    Clin Toxicol; 1970 Mar; 3(1):151-7. PubMed ID: 5520388
    [No Abstract]   [Full Text] [Related]  

  • 19. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sources of drug information: FDA-approved labeling and other official FDA sources.
    Lindstrom JA
    Dermatol Ther; 2009; 22(3):246-56. PubMed ID: 19453349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.